ERT to Expand Asia-Pacific Operations

Share Article

Move to new Tokyo location enables accommodate growing APAC operations

News Image
“By consolidating our offices into one, expanded location, we will be better able to improve our delivery of the services that are critical to ensuring successful clinical trials,” said Hiroki Mitsuhashi, General Manager, APAC, ERT.

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, has announced it will move its Japan-based offices to an expanded facility in central Tokyo this spring. In order to accommodate growing operations in the APAC region, ERT will consolidate its satellite offices, occupied by recently-acquired Biomedical Systems, into one location on April 1.

“By consolidating our offices into one, expanded location, we will be better able to meet our customers’ unique needs and improve our delivery of the services that are critical to ensuring successful clinical trials,” said Hiroki Mitsuhashi, General Manager, APAC, ERT.

ERT’s new Japanese office is located at:
2-13-13-2F Nihonbashi Kayabacho, Chuo-ku, Tokyo Japan 103-0025
03-6478-6170 TEL
03-6478-6171 FAX

For additional information, contact the ERT Administrative Group at 03-3561-1531.

About ERT
ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that its customers can move ahead with confidence. With nearly 50 years of clinical and therapeutic experience, ERT balances knowledge of what works with a vision for what’s next, so it can adapt without compromising standards.

Powered by the company’s EXPERT® technology platform, ERT’s solutions enhance trial oversight, enable site optimization, increase patient engagement and measure the efficacy of new clinical treatments while ensuring patient safety. Since 2013, more than half of all FDA drug approvals came from ERT-supported studies. Pharma companies, biotechs and CROs have relied on ERT solutions across 15,000 studies, spanning more than four million patients to date. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly ─ and with confidence.

For more information, go to ert.com or follow us on LinkedIn and Twitter.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Christine Tobin
ERT
+1 4127194568
Email >
Visit website